Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension of candesartan cilexetil in hypertensive children
2007-001545-17Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- May 2007
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of candesartan cilexetil in hypertension (HTN), sponsored by AstraZeneca. Primary endpoints: Blood pressure response rate and Blood pressure measurements over time. Started May 2007; status: completed.
02
Drugs
candesartan cilexetil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2007-001545-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001545-17.